ARCHIVES

ASCO Proposes Two IOM Workshops On Changing Clinical Trials Group System

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

Rev/Vel/Dex Response Rate High In Phase I/II Study

January 25, 2008

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

Zometa Can Reduce Risk Of Skeletal-Related Events

August 26, 2011

New Treatment Modalities For Endometrial Cancer

March 26, 2004

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014